They asked about my height, weight and how much weight I wanted to lose
This means it primarily targets growth hormone release without significantly impacting other hormones like cortisol or prolactin
Experimental research suggests DSIP may influence central neurotransmitter balance, potentially supporting inhibitory tone without direct receptor agonism
Sermorelin's FDA Journey: Approved, Discontinued, and Compounded Sermorelin acetate (Geref) was FDA-approved in 1997 for pediatric GHD 1 and in 1990 for diagnostic use.26 The manufacturer discontinued Geref in 2008 due to "manufacturing difficulties," not safety or efficacy concerns.12 In 2013, the FDA confirmed it wasn't withdrawn for safety/effectiveness, allowing for potential generic approvals.12 Currently, Sermorelin is primarily available as a compounded medication 3, which is permitted but not individually FDA-approved like mass-produced drugs.22 5.2
doi: 10.3390/antibiotics12081304 [DOI] [PMC free article] [PubMed] [Google Scholar] 32.Anes J, McCusker MP, Fanning S, Martins M